Position in ROIV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,177,637
+$257,028 QoQ
Shares Held
33,276
+0.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#225
of 494 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $12,966,883 across 12 Biotechnology names. ROIV ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,767 | $3,361,371 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,641 | $1,646,769 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
33,276 | $1,177,637 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
4,627 | $1,114,968 | |
| 5 | EXEL |
Exelixis, Inc.
|
18,536 | $1,008,543 | |
| 6 | CYTK |
Cytokinetics Inc
|
10,012 | $852,922 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,423 | $849,578 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
14,278 | $816,987 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,177,637 | 33,276 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $920,609 | 33,235 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $692,924 | 31,932 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $486,399 | 32,148 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $360,346 | 31,974 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $322,617 | 31,974 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $384,096 | 32,468 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $391,529 | 33,928 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $285,326 | 26,994 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $293,222 | 27,820 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||